Trulieve Cannabis Corp. (NYSE:TRLV) Stock Short Interest Declines 47.1%

Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 3,841,922 shares, a decline of 47.1% from the October 15th total of 7,259,177 shares. Based on an average daily trading volume, of 1,140,524 shares, the short-interest ratio is presently 3.4 days. Approximately 2.1% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on TRLV. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price target on shares of Trulieve Cannabis in a report on Monday, November 2nd. Wall Street Zen cut Trulieve Cannabis from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Trulieve Cannabis in a research note on Friday, September 11th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $15.00.

Get Our Latest Research Report on TRLV

Trulieve Cannabis Trading Down 5.0%

Shares of NYSE:TRLV traded down $0.55 during midday trading on Monday, reaching $10.36. 1,855,359 shares of the company’s stock traded hands, compared to its average volume of 1,349,505. The company has a fifty day simple moving average of $11.10. Trulieve Cannabis has a 1 year low of $4.62 and a 1 year high of $13.28. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.52 and a quick ratio of 3.65.

Trulieve Cannabis (NYSE:TRLV – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. The company had revenue of $230.20 million during the quarter, compared to analysts’ expectations of $221.79 million. Trulieve Cannabis had a negative net margin of 41.22% and a negative return on equity of 0.34%. On average, equities research analysts forecast that Trulieve Cannabis will post 0.13 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Trulieve Cannabis

A number of hedge funds have recently added to or reduced their stakes in the business. Marshall Wace LLP acquired a new stake in shares of Trulieve Cannabis during the 3rd quarter worth about $18,722,000. State Street Corp purchased a new stake in Trulieve Cannabis in the 3rd quarter valued at approximately $8,878,000. Jump Financial LLC purchased a new position in shares of Trulieve Cannabis in the 3rd quarter valued at about $1,992,000. HighTower Advisors LLC acquired a new stake in Trulieve Cannabis in the 3rd quarter valued at about $1,530,000. Finally, Landscape Capital Management L.L.C. purchased a new position in shares of Trulieve Cannabis during the third quarter valued at approximately $1,164,000.

About Trulieve Cannabis

(Get Free Report)

Trulieve Cannabis Corp. is a U.S. cannabis company that cultivates, processes and sells cannabis products through a vertically integrated business. Its offerings include flower, concentrates, vape products, edibles and other cannabis products, sold under brands such as Trulieve and Modern Flower. Founded in Florida in 2015, the company built its business in that state and expanded into other U.S. markets, including Arizona and Pennsylvania. Its operations and product offerings are shaped by the regulations in each state where it operates.

Further Reading

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.